Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06APK
|
||||
| Former ID |
DIB009024
|
||||
| Drug Name |
Rinfabate
|
||||
| Synonyms |
RhIGFBP-3; Rinfabate, Insmed; RhIGF-BP3, Insmed; Insulin-like growth factor binding protein-3, Insmed
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2/3 | [521879] | ||
| Company |
Insmed Inc
|
||||
| CAS Number |
CAS 405341-12-0
|
||||
| Target and Pathway | |||||
| Target(s) | Insulin-like growth factor I receptor | Target Info | Modulator | [527486] | |
| KEGG Pathway | Ras signaling pathway | ||||
| Rap1 signaling pathway | |||||
| HIF-1 signaling pathway | |||||
| FoxO signaling pathway | |||||
| Oocyte meiosis | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| AMPK signaling pathway | |||||
| Focal adhesion | |||||
| Adherens junction | |||||
| Signaling pathways regulating pluripotency of stem cells | |||||
| Long-term depression | |||||
| Ovarian steroidogenesis | |||||
| Progesterone-mediated oocyte maturation | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Proteoglycans in cancer | |||||
| Glioma | |||||
| Prostate cancer | |||||
| Melanoma | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.